Altered uterine artery blood flow impedance after danazol therapy: possible mode of action in dysfunctional uterine bleeding
Other
OA: closed
CC0
⤵ 6 in-corpus citations
AI-generated summary
This paper investigated changes in uterine artery blood flow impedance following danazol therapy and proposes this as a potential mechanism for treating dysfunctional uterine bleeding.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To test the hypothesis that danazol increases the impedance to uterine circulation and hence reduces the effective uterine blood flow after a predetermined period of therapy.
DESIGN: Prospective, longitudinal study.
SETTING: Reproductive medicine unit of a university teaching hospital.
PATIENT(S): Eight premenopausal women with dysfunctional uterine bleeding.
INTERVENTION(S): Six weeks of danazol therapy.
MAIN OUTCOME MEASURE(S): The uterine artery blood flow impedance as indicated by the pulsatility and resistance indices; the hormonal profile (E2, FSH, and LH levels); the uterine dimensions (length, width, anteroposterior diameter, and area); and the endometrial thickness.
RESULT(S): The indices of uterine artery impedance were significantly increased after danazol therapy, indicating a possible reduction in the effective uterine artery blood flow. There was no statistically significant change in the hormonal profile, uterine dimensions, or endometrial thickness.
CONCLUSION(S): Danazol therapy for 6 weeks results in a significant increase in the uterine artery impedance and hence a possible reduction in the effective uterine artery blood flow. This may explain in part its efficacy in the management of dysfunctional uterine bleeding and in the preoperative preparation of women undergoing endoscopic endometrial ablation. The exact mechanism for its action in this regard remains to be determined but appears to be independent of E2 levels. This preliminary finding may help in monitoring the treatment of dysfunctional uterine bleeding, preoperative and postoperative investigation of women undergoing endoscopic endometrial ablation, and the development of alternative treatment strategies for dysfunctional uterine bleeding in the future.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (23)
- Clinical studies with an antigonadotropin-Danazol via openalex
- Danazol binding and translocation of steroid receptors via openalex
- Danazol binding to rat androgen, glucocorticoid, progesterone, and estrogen receptors: correlation with biologic activity via openalex
- Danazol inhibition of steroidogenesis in the human corpus luteum via openalex
- [Effects of danazol on the endometrium during peri-menopausal meno-metrorrhagia] via openalex
- Endometrial ablation in the treatment of menorrhagia via openalex
- Endometrial thickness, morphology, vascular penetration and velocimetry in predicting implantation in an in vitro fertilization program via openalex
- Hormonal changes associated with Danazol therapy via openalex
- Hormonal inhibition of the endometrium for resectoscopic endometrial ablation via openalex
- How does danazol work? via openalex
- Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia via openalex
- Reduction of menstrual blood loss by danazol in unexplained menorrhagia: lack of effect of placebo via openalex
- The effects of danazol, mefenamic acid, norethisterone and a progesterone-impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia via openalex
- The effects of danazol on gonadotropins and steroid blood levels in normal and anovulatory women via openalex
- The influence of danazol on pituitary function and on the ovarian follicular hormone secretion in premenopausal women via openalex
- doi:10.1016/s0015-0282(16)58231-4 via openalex
- doi:10.3109/00016348409156996 via openalex
- doi:10.1016/0002-9378(81)90611-6 via openalex
- doi:10.1046/j.1469-0705.1997.08060408.x via openalex
- doi:10.3109/00016346609158455 via openalex
- doi:10.1016/s0015-0282(16)58218-1 via openalex
- doi:10.1016/s0140-6736(65)91606-5 via openalex
- doi:10.1074/jbc.271.46.29483 via openalex
Cited by (5)
- Danazol as a Treatment for Uterine Arteriovenous Malformation: A Case Report 2023
- Gestrinone versus danazol as preoperative treatment for hysteroscopic surgery: a prospective, randomized evaluation 2006
- Successful Medical Treatment With Danazol After Failed Embolization of Uterine Arteriovenous Malformation 2003
- Hemodynamic effect of danazol therapy in women with uterine leiomyomata 2003
- Successful medical treatment with danazol after failed embolization of uterine arteriovenous malformation 2003
Source provenance
- openalex
- last seen: 2026-05-11T06:09:19.794676+00:00
- pubmed
- last seen: 2026-10-08T20:58:57.924351+00:00
License: CC0
· commercial use OK